美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Actuate Therapeutics Inc

1.07

-0.0800-6.96%

盤後：1.080.0100+0.93%19:30 EDT

成交量：23.96萬

成交額：26.72萬

市值：2,560.07萬

市盈率：-1.21

高：1.23

開：1.15

低：1.03

收：1.15

52周最高：8.49

52周最低：0.9000

股本：2,392.59萬

流通股本：860.40萬

量比：0.51

換手率：2.78%

股息：- -

股息率：- -

每股收益(TTM):-0.8859

每股收益(LYR):-1.0574

淨資產收益率：-553.75%

總資產收益率：-213.40%

市淨率：25.88

市盈率(LYR):-1.01

資料載入中...

總覽公司新聞公告

Actuate披露振奮人心的臨床前數據：Elraglusib聯合Ras抑制劑Zoldonrasib與Daraxonrasib展現協同抗腫瘤活性

Actuate Therapeutics旗下Elraglusib獲選用於Beacon2高風險小兒神經母細胞瘤試驗評估

Actuate Therapeutics公布ASCO海報展示，揭示Elraglusib一線治療轉移性胰腺癌的強勁臨床及生物標誌物數據

Actuate Therapeutics Inc：FDA批准口服Elraglusib用於晚期癌症患者的1/2期研究新藥臨床試驗申請

Actuate Therapeutics宣佈口服Elraglusib新藥臨床試驗申請獲FDA批准，並公布推進其研發項目的戰略舉措

Actuate Therapeutics任命行業資深人士Martin Huber博士為獨立董事

健康巡禮：Actuate Therapeutics藥物在胰腺癌試驗中提高生存率

Actuate Therapeutics公布《自然-醫學》臨床試驗結果：Elraglusib聯合化療使未經治療的轉移性胰腺導管腺癌患者生存率翻倍

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/ACTU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACTU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACTU\",,,,,undefined,":{"symbol":"ACTU","market":"US","secType":"STK","nameCN":"Actuate Therapeutics Inc","latestPrice":1.07,"timestamp":1789156800000,"preClose":1.15,"halted":0,"volume":239600,"hourTrading":{"tag":"盘后","latestPrice":1.08,"preClose":1.07,"latestTime":"19:30 EDT","volume":1189,"amount":1288.9,"timestamp":1789169407283,"change":0.01,"changeRate":0.009346,"amplitude":0.028037},"delay":0,"changeRate":-0.06956521739130422,"floatShares":8604000,"shares":23925852,"eps":-0.885897,"marketStatus":"休市中","change":-0.08,"latestTime":"09-11 16:00:00 EDT","open":1.15,"high":1.2299,"low":1.03,"amount":267235.8234,"amplitude":0.173826,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.885897,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1723521600000,"exchange":"NASDAQ","adjPreClose":1.15,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.15,"latestTime":"08:51 EDT","volume":15,"amount":18.4098015,"timestamp":1789131113326,"change":0.02,"changeRate":0.017391,"amplitude":0.13913},"postHourTrading":{"tag":"盘后","latestPrice":1.08,"preClose":1.07,"latestTime":"19:30 EDT","volume":1189,"amount":1288.9,"timestamp":1789169407283,"change":0.01,"changeRate":0.009346,"amplitude":0.028037},"volumeRatio":0.5127518122098006},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACTU\",,,,,undefined,":{"symbol":"ACTU","floatShares":8604000,"roa":"-213.40%","roe":"-553.75%","lyrEps":-1.05737,"volumeRatio":0.5127518122098006,"shares":23925852,"dividePrice":0,"high":1.2299,"amplitude":0.173826,"preClose":1.15,"low":1.03,"week52Low":0.9,"pbRate":"25.88","week52High":8.49,"institutionHeld":0,"latestPrice":1.07,"eps":-0.885897,"divideRate":0,"volume":239600,"delay":0,"ttmEps":-0.885897,"open":1.15,"prevYearClose":6.12,"prevWeekClose":1.48,"prevMonthClose":1.52,"prevQuarterClose":1.53,"fiveDayClose":1.37,"twentyDayClose":0.9751,"sixtyDayClose":2.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACTU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"ACTU","fiscalQuarterEnding":"2026/06","expectedEps":-0.21,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2026-05-14","symbol":"ACTU","fiscalQuarterEnding":"2026/03","expectedEps":-0.23,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2026-03-26","symbol":"ACTU","fiscalQuarterEnding":"2025/12","expectedEps":-0.24,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2025-11-13","symbol":"ACTU","fiscalQuarterEnding":"2025/09","expectedEps":-0.27,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2025-08-14","symbol":"ACTU","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACTU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACTU\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1756180800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACTU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACTU","date":"2026-09-11","current":-1.207815,"percent":0.965779,"low":-9.225925,"twenty":-6.442378,"median":-5.478936,"eighty":-2.707024,"high":-1.077501,"avg":-4.92875,"sd":1.835194,"marketCap":27616332},"quantilePoints":[{"date":"2024-07-25","current":-6.211408,"twenty":-6.211408,"median":-6.211408,"eighty":-6.211408,"marketCap":172493433},{"date":"2024-08-09","current":-5.505609,"twenty":-6.211408,"median":-6.211408,"eighty":-6.070248,"marketCap":152893088},{"date":"2024-08-16","current":-5.987349,"twenty":-6.211408,"median":-6.167236,"eighty":-5.841451,"marketCap":166271233},{"date":"2024-08-23","current":-5.560665,"twenty":-6.211408,"median":-5.987349,"eighty":-5.556536,"marketCap":154422018},{"date":"2024-08-30","current":-5.540019,"twenty":-6.211408,"median":-5.870355,"eighty":-5.533137,"marketCap":153848669},{"date":"2024-09-06","current":-5.608839,"twenty":-6.158401,"median":-5.624324,"eighty":-5.529008,"marketCap":155759833},{"date":"2024-09-13","current":-5.512491,"twenty":-6.078798,"median":-5.608839,"eighty":-5.512491,"marketCap":153084204},{"date":"2024-09-20","current":-5.03075,"twenty":-6.012125,"median":-5.608839,"eighty":-5.509738,"marketCap":139706059},{"date":"2024-09-27","current":-4.249491,"twenty":-5.950186,"median":-5.560665,"eighty":-5.486339,"marketCap":122463357},{"date":"2024-10-04","current":-5.056014,"twenty":-5.921282,"median":-5.540019,"eighty":-5.041842,"marketCap":145706004},{"date":"2024-10-11","current":-4.981461,"twenty":-5.86072,"median":-5.519373,"eighty":-4.824223,"marketCap":143557524},{"date":"2024-10-18","current":-4.920464,"twenty":-5.785018,"median":-5.512491,"eighty":-4.844556,"marketCap":141799677},{"date":"2024-10-25","current":-5.774428,"twenty":-5.765917,"median":-5.512491,"eighty":-4.844556,"marketCap":166409538},{"date":"2024-11-01","current":-5.306781,"twenty":-5.809795,"median":-5.512491,"eighty":-4.893354,"marketCap":152932709},{"date":"2024-11-08","current":-5.937088,"twenty":-5.927371,"median":-5.540019,"eighty":-4.957062,"marketCap":171097131},{"date":"2024-11-15","current":-5.958745,"twenty":-5.939799,"median":-5.550342,"eighty":-5.011034,"marketCap":169534600},{"date":"2024-11-22","current":-6.164693,"twenty":-5.973458,"median":-5.595075,"eighty":-5.037775,"marketCap":175394091},{"date":"2024-11-29","current":-5.581175,"twenty":-6.024512,"median":-5.608839,"eighty":-5.04517,"marketCap":158792200},{"date":"2024-12-06","current":-6.144098,"twenty":-6.055165,"median":-5.638088,"eighty":-5.051947,"marketCap":174808142},{"date":"2024-12-13","current":-5.917556,"twenty":-6.037784,"median":-5.643249,"eighty":-5.107523,"marketCap":168362702},{"date":"2024-12-20","current":-4.647547,"twenty":-6.017783,"median":-5.638088,"eighty":-5.04517,"marketCap":132229175},{"date":"2024-12-27","current":-6.068584,"twenty":-6.019156,"median":-5.638088,"eighty":-5.043814,"marketCap":172659662},{"date":"2025-01-03","current":-5.718473,"twenty":-6.013664,"median":-5.622603,"eighty":-5.049236,"marketCap":162698527},{"date":"2025-01-10","current":-5.697878,"twenty":-5.992612,"median":-5.622603,"eighty":-5.054658,"marketCap":162112578},{"date":"2025-01-17","current":-5.917556,"twenty":-5.969958,"median":-5.636367,"eighty":-5.146627,"marketCap":168362702},{"date":"2025-01-24","current":-6.940428,"twenty":-6.032033,"median":-5.643249,"eighty":-5.178584,"marketCap":197464839},{"date":"2025-01-31","current":-6.199017,"twenty":-6.064465,"median":-5.677284,"eighty":-5.209185,"marketCap":176370673},{"date":"2025-02-07","current":-6.047989,"twenty":-6.091559,"median":-5.691423,"eighty":-5.241176,"marketCap":172073713},{"date":"2025-02-14","current":-5.327173,"twenty":-6.072917,"median":-5.687582,"eighty":-5.255778,"marketCap":151565495},{"date":"2025-02-21","current":-5.279119,"twenty":-6.065838,"median":-5.658037,"eighty":-5.254405,"marketCap":150198280},{"date":"2025-02-28","current":-4.970198,"twenty":-6.060665,"median":-5.639808,"eighty":-5.174772,"marketCap":141409044},{"date":"2025-03-07","current":-4.771115,"twenty":-6.057666,"median":-5.608839,"eighty":-5.040292,"marketCap":135744870},{"date":"2025-03-14","current":-5.189762,"twenty":-6.053039,"median":-5.581175,"eighty":-5.033989,"marketCap":141604361},{"date":"2025-03-21","current":-4.831847,"twenty":-6.048768,"median":-5.560665,"eighty":-5.014488,"marketCap":131838543},{"date":"2025-03-28","current":-5.655051,"twenty":-6.042497,"median":-5.560665,"eighty":-5.033989,"marketCap":154299924},{"date":"2025-04-04","current":-4.932064,"twenty":-6.028767,"median":-5.540019,"eighty":-4.987939,"marketCap":134572972},{"date":"2025-04-11","current":-5.483252,"twenty":-6.017783,"median":-5.519391,"eighty":-4.984609,"marketCap":149612331},{"date":"2025-04-17","current":-5.726634,"twenty":-6.012291,"median":-5.540019,"eighty":-4.990995,"marketCap":156253088},{"date":"2025-04-25","current":-6.406672,"twenty":-6.045243,"median":-5.553757,"eighty":-4.998855,"marketCap":174808142},{"date":"2025-05-02","current":-7.537682,"twenty":-6.061192,"median":-5.567445,"eighty":-5.009067,"marketCap":205668127},{"date":"2025-05-09","current":-7.408833,"twenty":-6.107591,"median":-5.601957,"eighty":-5.032369,"marketCap":202152432},{"date":"2025-05-16","current":-8.179286,"twenty":-6.139979,"median":-5.636367,"eighty":-5.039569,"marketCap":206987413},{"date":"2025-05-23","current":-7.830407,"twenty":-6.178422,"median":-5.644452,"eighty":-5.043814,"marketCap":198158566},{"date":"2025-05-30","current":-8.194792,"twenty":-6.211408,"median":-5.662735,"eighty":-5.049236,"marketCap":207379806},{"date":"2025-06-06","current":-7.047366,"twenty":-6.281396,"median":-5.690843,"eighty":-5.056014,"marketCap":178342709},{"date":"2025-06-13","current":-6.675228,"twenty":-6.406672,"median":-5.69465,"eighty":-5.089546,"marketCap":168925272},{"date":"2025-06-20","current":-5.806906,"twenty":-6.42894,"median":-5.722554,"eighty":-5.141086,"marketCap":146951253},{"date":"2025-06-27","current":-4.512175,"twenty":-6.410449,"median":-5.697878,"eighty":-5.08284,"marketCap":114186421},{"date":"2025-07-03","current":-5.109147,"twenty":-6.389172,"median":-5.691014,"eighty":-5.046525,"marketCap":129293559},{"date":"2025-07-11","current":-4.791279,"twenty":-6.365148,"median":-5.677284,"eighty":-5.035608,"marketCap":121249498},{"date":"2025-07-18","current":-4.853302,"twenty":-6.320988,"median":-5.645656,"eighty":-4.991444,"marketCap":122819071},{"date":"2025-07-25","current":-5.419262,"twenty":-6.287654,"median":-5.638088,"eighty":-4.976956,"marketCap":137141423},{"date":"2025-08-01","current":-5.620836,"twenty":-6.265937,"median":-5.628589,"eighty":-4.986182,"marketCap":142242535},{"date":"2025-08-08","current":-6.527901,"twenty":-6.287654,"median":-5.632466,"eighty":-4.991444,"marketCap":165196967},{"date":"2025-08-15","current":-6.908485,"twenty":-6.414227,"median":-5.639808,"eighty":-4.995735,"marketCap":170525437},{"date":"2025-08-22","current":-6.442036,"twenty":-6.458702,"median":-5.650353,"eighty":-5.00125,"marketCap":159011858},{"date":"2025-08-29","current":-6.908485,"twenty":-6.483225,"median":-5.670419,"eighty":-5.019908,"marketCap":170525437},{"date":"2025-09-05","current":-7.328709,"twenty":-6.512404,"median":-5.690843,"eighty":-5.033989,"marketCap":180898030},{"date":"2025-09-12","current":-5.859066,"twenty":-6.574176,"median":-5.69465,"eighty":-5.040292,"marketCap":144622132},{"date":"2025-09-19","current":-6.375067,"twenty":-6.549229,"median":-5.726634,"eighty":-5.04517,"marketCap":157358843},{"date":"2025-09-26","current":-6.175411,"twenty":-6.549229,"median":-5.729418,"eighty":-5.051947,"marketCap":152430635},{"date":"2025-10-03","current":-6.212557,"twenty":-6.533707,"median":-5.754096,"eighty":-5.069427,"marketCap":153347511},{"date":"2025-10-10","current":-7.512643,"twenty":-6.537578,"median":-5.770478,"eighty":-5.097386,"marketCap":185438171},{"date":"2025-10-17","current":-7.24334,"twenty":-6.589924,"median":-5.79172,"eighty":-5.109147,"marketCap":178790820},{"date":"2025-10-24","current":-6.732591,"twenty":-6.670885,"median":-5.814177,"eighty":-5.112248,"marketCap":166183775},{"date":"2025-10-31","current":-6.110407,"twenty":-6.6744,"median":-5.859066,"eighty":-5.12,"marketCap":150826102},{"date":"2025-11-07","current":-5.785385,"twenty":-6.670885,"median":-5.869501,"eighty":-5.13638,"marketCap":142803437},{"date":"2025-11-14","current":-5.536933,"twenty":-6.66337,"median":-5.85039,"eighty":-5.154603,"marketCap":136670768},{"date":"2025-11-21","current":-5.868654,"twenty":-6.637844,"median":-5.836285,"eighty":-5.160645,"marketCap":141551867},{"date":"2025-11-28","current":-7.352682,"twenty":-6.647528,"median":-5.86386,"eighty":-5.168486,"marketCap":177346592},{"date":"2025-12-05","current":-7.082858,"twenty":-6.676544,"median":-5.869501,"eighty":-5.172026,"marketCap":170838460},{"date":"2025-12-12","current":-7.150314,"twenty":-6.706669,"median":-5.884194,"eighty":-5.183365,"marketCap":172465493},{"date":"2025-12-19","current":-6.764853,"twenty":-6.718803,"median":-5.896423,"eighty":-5.185781,"marketCap":163168162},{"date":"2025-12-26","current":-6.321572,"twenty":-6.721745,"median":-5.917556,"eighty":-5.189762,"marketCap":152476231},{"date":"2026-01-02","current":-5.897564,"twenty":-6.709975,"median":-5.917556,"eighty":-5.218313,"marketCap":142249167},{"date":"2026-01-09","current":-6.051748,"twenty":-6.706828,"median":-5.918043,"eighty":-5.231645,"marketCap":145968099},{"date":"2026-01-16","current":-5.12664,"twenty":-6.706347,"median":-5.916837,"eighty":-5.218313,"marketCap":123654504},{"date":"2026-01-23","current":-5.251915,"twenty":-6.701519,"median":-5.896423,"eighty":-5.230096,"marketCap":126676137},{"date":"2026-01-30","current":-4.567721,"twenty":-6.691045,"median":-5.884194,"eighty":-5.187481,"marketCap":110173374},{"date":"2026-02-06","current":-4.162986,"twenty":-6.680588,"median":-5.869501,"eighty":-5.163192,"marketCap":100411176},{"date":"2026-02-13","current":-4.085894,"twenty":-6.675886,"median":-5.86386,"eighty":-5.121593,"marketCap":98551710},{"date":"2026-02-20","current":-4.085894,"twenty":-6.6744,"median":-5.836285,"eighty":-5.109147,"marketCap":98551710},{"date":"2026-02-27","current":-3.806434,"twenty":-6.670885,"median":-5.810835,"eighty":-5.051947,"marketCap":91811145},{"date":"2026-03-06","current":-3.083693,"twenty":-6.66337,"median":-5.801368,"eighty":-5.014488,"marketCap":74378649},{"date":"2026-03-13","current":-2.457318,"twenty":-6.638594,"median":-5.7914,"eighty":-4.984609,"marketCap":59270486},{"date":"2026-03-20","current":-2.409136,"twenty":-6.610668,"median":-5.770478,"eighty":-4.925104,"marketCap":58108320},{"date":"2026-03-27","current":-2.421357,"twenty":-6.609918,"median":-5.754096,"eighty":-4.858871,"marketCap":53821570},{"date":"2026-04-02","current":-2.656026,"twenty":-6.605591,"median":-5.74824,"eighty":-4.848283,"marketCap":59037758},{"date":"2026-04-10","current":-2.016167,"twenty":-6.591355,"median":-5.726634,"eighty":-4.839764,"marketCap":44815069},{"date":"2026-04-17","current":-2.293524,"twenty":-6.585305,"median":-5.718473,"eighty":-4.830404,"marketCap":50980105},{"date":"2026-04-24","current":-2.698891,"twenty":-6.578607,"median":-5.699843,"eighty":-4.807832,"marketCap":59990542},{"date":"2026-05-01","current":-3.13626,"twenty":-6.553112,"median":-5.691423,"eighty":-4.789745,"marketCap":69712330},{"date":"2026-05-08","current":-3.562962,"twenty":-6.537578,"median":-5.687496,"eighty":-4.757961,"marketCap":79197001},{"date":"2026-05-15","current":-3.221727,"twenty":-6.536778,"median":-5.667354,"eighty":-4.71569,"marketCap":69384970},{"date":"2026-05-22","current":-2.688476,"twenty":-6.532441,"median":-5.647014,"eighty":-4.678926,"marketCap":57900561},{"date":"2026-05-29","current":-2.310756,"twenty":-6.527901,"median":-5.644452,"eighty":-4.628468,"marketCap":49765772},{"date":"2026-06-05","current":-2.155224,"twenty":-6.519006,"median":-5.637377,"eighty":-4.558084,"marketCap":46416152},{"date":"2026-06-12","current":-2.210771,"twenty":-6.519006,"median":-5.632466,"eighty":-4.465658,"marketCap":47612445},{"date":"2026-06-18","current":-2.277428,"twenty":-6.511576,"median":-5.624712,"eighty":-4.24967,"marketCap":49047996},{"date":"2026-06-26","current":-2.177443,"twenty":-6.50229,"median":-5.608839,"eighty":-4.114631,"marketCap":46894669},{"date":"2026-07-02","current":-1.599754,"twenty":-6.493669,"median":-5.581175,"eighty":-4.09553,"marketCap":34453226},{"date":"2026-07-10","current":-1.366457,"twenty":-6.488137,"median":-5.560665,"eighty":-4.043493,"marketCap":29428797},{"date":"2026-07-17","current":-1.844161,"twenty":-6.487388,"median":-5.541012,"eighty":-3.870035,"marketCap":39716914},{"date":"2026-07-24","current":-1.399785,"twenty":-6.484054,"median":-5.540019,"eighty":-3.587625,"marketCap":30146573},{"date":"2026-07-31","current":-1.2998,"twenty":-6.481308,"median":-5.528162,"eighty":-3.243011,"marketCap":27993246},{"date":"2026-08-07","current":-1.366457,"twenty":-6.480034,"median":-5.512491,"eighty":-3.170397,"marketCap":29428797},{"date":"2026-08-14","current":-1.083278,"twenty":-6.478922,"median":-5.507858,"eighty":-3.110658,"marketCap":23330098},{"date":"2026-08-21","current":-1.438793,"twenty":-6.475391,"median":-5.505609,"eighty":-3.053053,"marketCap":29428797},{"date":"2026-08-28","current":-1.984178,"twenty":-6.462834,"median":-5.488455,"eighty":-2.929275,"marketCap":40584001},{"date":"2026-09-04","current":-1.608476,"twenty":-6.447249,"median":-5.483192,"eighty":-2.791036,"marketCap":32899456},{"date":"2026-09-11","current":-1.350181,"twenty":-6.442378,"median":-5.478936,"eighty":-2.707024,"marketCap":27616332}],"updateTime":1789223135927},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACTU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193881960","title":"Actuate披露振奮人心的臨床前數據：Elraglusib聯合Ras抑制劑Zoldonrasib與Daraxonrasib展現協同抗腫瘤活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1193881960","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193881960?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 19:06","pubTimestamp":1788951974,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics公布了一系列令人瞩目的临床前研究结果，揭示其主打候选药物Elraglusib在与两款Ras抑制剂——Zoldonrasib及Daraxonrasib联合使用时，呈现出显著的协同增效作用。研究显示，当Elraglusib与上述Ras抑制剂搭配给药时，其抗肿瘤效果远超单药方案。具体而言，Elraglusib作为一款糖原合成酶激酶-3beta抑制剂，其作用机制与Ras抑制剂的靶向路径形成巧妙互补。Actuate管理层对这批数据寄予厚望，认为其不仅验证了Elraglusib的联合用药潜力，更为后续临床开发指明了清晰方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125886661","title":"Actuate Therapeutics旗下Elraglusib獲選用於Beacon2高風險小兒神經母細胞瘤試驗評估","url":"https://stock-news.laohu8.com/highlight/detail?id=1125886661","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125886661?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 19:46","pubTimestamp":1781005576,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics旗下药物Elraglusib已被选中，将在Beacon2临床试验中接受评估，用于治疗高风险小儿神经母细胞瘤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154214300","title":"Actuate Therapeutics公布ASCO海報展示，揭示Elraglusib一線治療轉移性胰腺癌的強勁臨床及生物標誌物數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1154214300","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154214300?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 19:01","pubTimestamp":1780311678,"startTime":"0","endTime":"0","summary":"生物制药公司Actuate Therapeutics Inc宣布，其候选药物Elraglusib在一线治疗转移性胰腺癌的临床研究中，获得了令人瞩目的临床疗效与生物标志物数据，相关成果将在美国临床肿瘤学会年会上以海报形式进行展示。此次公布的数据进一步证实了Elraglusib在治疗这一难治性癌症方面的潜力。胰腺癌，尤其是转移性胰腺癌，长期以来缺乏有效的治疗手段，患者预后极差。Elraglusib的新数据为这一领域带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187375862","title":"Actuate Therapeutics Inc：FDA批准口服Elraglusib用於晚期癌症患者的1/2期研究新藥臨床試驗申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1187375862","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187375862?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 19:01","pubTimestamp":1778497280,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics Inc宣布，美国食品药品监督管理局（FDA）已批准其口服药物Elraglusib用于治疗晚期癌症患者的新药临床试验申请，该申请旨在启动一项1/2期临床研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107661115","title":"Actuate Therapeutics宣佈口服Elraglusib新藥臨床試驗申請獲FDA批准，並公布推進其研發項目的戰略舉措","url":"https://stock-news.laohu8.com/highlight/detail?id=1107661115","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107661115?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 19:01","pubTimestamp":1778497278,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics公司今日宣布，其口服Elraglusib的新药临床试验申请已获得美国食品药品监督管理局的批准。与此同时，公司还公布了一系列旨在加速Elraglusib研发项目的战略性举措。\n这一监管进展标志着Elraglusib的开发进入了新的阶段。获得FDA的临床试验许可，使得公司能够启动针对该口服制剂的研究，进一步探索其在相关适应症中的潜力。\n除了监管层面的突破，Actuate Therapeutics也同步启动了多项战略计划，以全面推动Elraglusib项目的进展。这些举措旨在优化开发路径，整合资源，并加速该候选药物从临床研究向潜在商业化迈进的步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149138255","title":"Actuate Therapeutics任命行業資深人士Martin Huber博士為獨立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1149138255","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149138255?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 20:47","pubTimestamp":1778071646,"startTime":"0","endTime":"0","summary":"芝加哥和德克萨斯州沃思堡——临床阶段生物制药公司Actuate Therapeutics Inc 今日宣布，任命医学博士Martin Huber为董事会独立董事，该任命立即生效。此次人事变动将强化公司领导团队实力，正值其核心候选药物elraglusib针对多种难治性癌症适应症向注册研究和商业化阶段推进的关键时期。Actuate Therapeutics总裁兼首席执行官Daniel Schmitt表示：\"我们非常荣幸欢迎Marty加入董事会。Huber博士近期曾担任Mersana Therapeutics总裁兼首席执行官，直至该公司于2026年1月被Day One Pharmaceuticals收购。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629605080","title":"健康巡禮：Actuate Therapeutics藥物在胰腺癌試驗中提高生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2629605080","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629605080?lang=zh_tw&edition=fundamental","pubTime":"2026-04-22 04:13","pubTimestamp":1776802421,"startTime":"0","endTime":"0","summary":"新药提高了晚期胰腺癌患者的生存率 一项中期试验的结果显示，接受Actuate Therapeutics公司开发的实验性药物联合化疗的晚期胰腺癌患者，一年后的存活人数是只接受化疗患者的两倍。研究人员在《自然-医学》  上报告说，接受Actuate公司的elraglusib治疗的患者一年后有44%存活，而只接受化疗的患者只有22%存活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nL4T414258:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112475621","title":"Actuate Therapeutics公布《自然-醫學》臨床試驗結果：Elraglusib聯合化療使未經治療的轉移性胰腺導管腺癌患者生存率翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1112475621","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112475621?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 20:45","pubTimestamp":1776170715,"startTime":"0","endTime":"0","summary":"生物制药公司Actuate Therapeutics Inc宣布，其重要的临床研究结果已在权威期刊《自然-医学》上正式发表。该研究数据显示，对于先前未接受过治疗的转移性胰腺导管腺癌患者，使用其核心在研药物Elraglusib联合标准化疗方案进行治疗，可以显著改善患者的生存结局，使患者的生存率实现翻倍增长。\n这一突破性发现为这种侵袭性强、治疗选择有限的难治性癌症提供了新的潜在治疗方向，展现了Elraglusib在联合疗法中的巨大应用潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}